Lumida
/AMRX
⌘K
Amneal Pharmaceuticals Inc

Amneal Pharmaceuticals Inc

AMRX
$17.87USD-1.05%-0.19 today

MARKET CAP

5.7B

P/E (TTM)

47.0x

FWD P/E

DAY RANGE

$18 – $18

52W RANGE

$9
$19

AI Summary

Stalk
Sell NowMedium

AMRX is entering a distribution phase after a sharp rally, with Bullish Exhaustion indicating waning upside momentum. Price has broken below the 9, 20, and 50 EMAs in a neutral OB/OS context, reinforcing a medium-term bearish bias. Under a Growth at Reasonable Price approach, selling participation into any bounce toward the EMAs is recommended while the long-term uptrend remains intact.

  • Q2 2026 revenue $796M (+10% YoY) and adjusted EBITDA $206M (+12% YoY) highlight strong execution.
  • Gross margin rose to 46.2% (+60 bps YoY) on favorable product mix and efficiencies.
  • Specialty segment forecast flat growth in 2026 due to Parkinson’s generic erosion.
Full analysis →
Insider Trades40 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Aug 12, 2026SellAMRXNikita ShahExecutive Vice President146,403$17.51$5.7B-7.22%+91.74%$2.6M-36.62%Buy Now
Aug 11, 2026SellAMRXJason B. DalyEVP, Chief Legal Officer216,613$17.41$5.7B-7.22%+91.74%$3.8M-43.59%Buy Now
Mar 3, 2026SellAMRXJason B. DalyEVP, Chief Legal Officer185,641$13.31$5.7B-7.22%+91.74%$2.5M-18.98%Buy Now
Mar 3, 2026SellAMRXNikita ShahExecutive Vice President255,109$13.31$5.7B-7.22%+91.74%$3.4M-14.37%Buy Now
Mar 3, 2026SellAMRXAndrew S BoyerExecutive Vice President275,307$13.31$5.7B-7.22%+91.74%$3.7M-14.61%Buy Now
Mar 3, 2026SellAMRXTasos KonidarisExecutive Vice President & CFO306,583$13.31$5.7B-7.22%+91.74%$4.1M-15.73%Buy Now
Mar 3, 2026SellAMRXChirag K. PatelPresident & Co-CEO350,978$13.31$5.7B-7.22%+91.74%$4.7M-8.07%Buy Now
Mar 3, 2026SellAMRXChintu PatelCo-CEO361,980$13.31$5.7B-7.22%+91.74%$4.8M-8.33%Buy Now
Nov 12, 2025SellAMRXNikita ShahExecutive Vice President263,712$7.33$5.7B-7.22%+91.74%$1.9M+0.00%Buy Now
Aug 22, 2025SellAMRXNikita ShahExecutive Vice President120,832$9.65$5.7B-7.22%+91.74%$1.2M-28.77%Buy Now
Aug 20, 2025SellAMRXAndrew S BoyerExecutive Vice President454,244$6.83$5.7B-7.22%+91.74%$3.1M-13.27%Buy Now
Aug 14, 2025SellAMRXNikita ShahExecutive Vice President71,694$9.29$5.7B-7.22%+91.74%$666.0K-21.15%Buy Now
Aug 13, 2025SellAMRXTasos KonidarisExecutive Vice President & CFO499,730$9.33$5.7B-7.22%+91.74%$4.7M-35.10%Buy Now
Aug 12, 2025SellAMRXJason B. DalyEVP, Chief Legal Officer22,000$9.05$5.7B-7.22%+91.74%$199.1K-67.47%Buy Now
Aug 12, 2025SellAMRXAndrew S BoyerExecutive Vice President33,436$9.05$5.7B-7.22%+91.74%$302.6K-11.53%Buy Now
Aug 12, 2025SellAMRXNikita ShahExecutive Vice President50,000$9.04$5.7B-7.22%+91.74%$452.0K-12.86%Buy Now
May 16, 2025SellAMRXNikita ShahExecutive Vice President49,140$7.58$5.7B-7.22%+91.74%$372.5K-11.22%Buy Now
Mar 5, 2025SellAMRXJason B. DalyEVP, Chief Legal Officer90,000$8.80$5.7B-7.22%+91.74%$792.2K-44.52%Buy Now
Mar 5, 2025SellAMRXTasos KonidarisExecutive Vice President & CFO100,000$8.91$5.7B-7.22%+91.74%$891.0K-13.85%Buy Now
Mar 5, 2025SellAMRXAndrew S BoyerExecutive Vice President125,000$8.89$5.7B-7.22%+91.74%$1.1M-30.11%Buy Now
Mar 3, 2025SellAMRXJason B. DalyEVP, Chief Legal Officer64,724$8.78$5.7B-7.22%+91.74%$568.2K-7.65%Buy Now
Mar 3, 2025SellAMRXNikita ShahExecutive Vice President134,481$8.77$5.7B-7.22%+91.74%$1.2M-6.15%Buy Now
Mar 3, 2025SellAMRXAndrew S BoyerExecutive Vice President145,342$8.77$5.7B-7.22%+91.74%$1.3M-6.87%Buy Now
Mar 3, 2025SellAMRXTasos KonidarisExecutive Vice President & CFO155,907$8.77$5.7B-7.22%+91.74%$1.4M-4.58%Buy Now
Mar 3, 2025SellAMRXChintu PatelCo-CEO320,835$8.77$5.7B-7.22%+91.74%$2.8M-9.41%Buy Now
Mar 3, 2025SellAMRXChirag K. PatelPresident & Co-CEO326,888$8.77$5.7B-7.22%+91.74%$2.9M-9.60%Buy Now
Mar 1, 2025SellAMRXNikita ShahExecutive Vice President10,985$8.67$5.7B-7.22%+91.74%$95.2K-3.43%Buy Now
Mar 1, 2025SellAMRXAndrew S BoyerExecutive Vice President11,737$8.67$5.7B-7.22%+91.74%$101.8K-4.07%Buy Now
Mar 1, 2025SellAMRXTasos KonidarisExecutive Vice President & CFO13,494$8.67$5.7B-7.22%+91.74%$117.0K-2.39%Buy Now
Nov 21, 2024SellAMRXJason B. DalySVP, Chief Legal Officer13,665$8.40$5.7B-7.22%+91.74%$114.8K-100.00%Buy Now
Nov 15, 2024SellAMRXJason B. DalySVP, Chief Legal Officer43,657$8.61$5.7B-7.22%+91.74%$375.9K-76.16%Buy Now
Aug 14, 2024SellAMRXAndrew S BoyerExecutive Vice President62,711$7.84$5.7B-7.22%+91.74%$491.4K-10.18%Buy Now
Aug 14, 2024SellAMRXNikita ShahExecutive Vice President100,000$7.75$5.7B-7.22%+91.74%$775.0K-25.53%Buy Now
Mar 12, 2024SellAMRXTasos KonidarisExecutive Vice President & CFO30,790$5.31$5.7B-7.22%+91.74%$163.5K-5.52%Buy Now
Mar 3, 2024SellAMRXJason B. DalySVP, Chief Legal Officer18,030$5.47$5.7B-7.22%+91.74%$98.6K-2.59%Buy Now
Mar 1, 2024SellAMRXTasos KonidarisExecutive Vice President & CFO49,280$5.47$5.7B-7.22%+91.74%$269.6K-2.26%Buy Now
Mar 1, 2024SellAMRXNikita ShahExecutive Vice President56,316$5.47$5.7B-7.22%+91.74%$308.0K-3.07%Buy Now
Mar 1, 2024SellAMRXAndrew S BoyerExecutive Vice President60,781$5.47$5.7B-7.22%+91.74%$332.5K-3.65%Buy Now
Feb 27, 2024SellAMRXAndrew S BoyerExecutive Vice President16,556$5.71$5.7B-7.22%+91.74%$94.5K-5.99%Buy Now
Feb 27, 2024SellAMRXNikita ShahExecutive Vice President18,670$5.71$5.7B-7.22%+91.74%$106.6K-5.25%Buy Now